3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostatic Neoplasms
6
Neuroendocrine Tumors
5
Neoplasms
4
Breast Neoplasms
4
Esophageal Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Large B-cell Lymphoma
1
Hypoxia
1
Hodgkin Disease
1
Hepatic Malignancies
1
Interventions
Cyclophosphamide
282
Rituximab
260
Etoposide
161
Filgrastim
155
Vincristine
145
Doxorubicin
134
Prednisone
117
Cytarabine
108
Radiotherapy
102
Peripheral Blood Stem Cell Transplantation
90
Methotrexate
90
fludarabine phosphate
87
Melphalan
78
Busulfan
71
Dexamethasone
59
Granulocyte Colony-Stimulating Factor
56
Carmustine
53
fludarabine
51
Bortezomib
46
Tacrolimus
44
Mycophenolic Acid
41
Antilymphocyte Serum
41
Ifosfamide
40
Leucovorin
39
Gemcitabine
38
Whole-Body Irradiation
36
Cyclosporine
35
Bendamustine Hydrochloride
34
sargramostim
33
Methylprednisolone
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphoma
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT03615664
2025-01-16
BURGUND
Polish Lymphoma Research Group
Phase 2
Completed
115 enrolled